ATE370238T1 - Cpg-freie synthetische gene und bakterielle plasmide - Google Patents

Cpg-freie synthetische gene und bakterielle plasmide

Info

Publication number
ATE370238T1
ATE370238T1 AT02722336T AT02722336T ATE370238T1 AT E370238 T1 ATE370238 T1 AT E370238T1 AT 02722336 T AT02722336 T AT 02722336T AT 02722336 T AT02722336 T AT 02722336T AT E370238 T1 ATE370238 T1 AT E370238T1
Authority
AT
Austria
Prior art keywords
cpg
synthetic genes
bacterial plasmids
free synthetic
free
Prior art date
Application number
AT02722336T
Other languages
English (en)
Inventor
Daniel Drocourt
Jean-Paul Reynes
Gerard Tiraby
Original Assignee
Cayla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8860962&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE370238(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cayla filed Critical Cayla
Application granted granted Critical
Publication of ATE370238T1 publication Critical patent/ATE370238T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
AT02722336T 2001-03-09 2002-03-11 Cpg-freie synthetische gene und bakterielle plasmide ATE370238T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0103274A FR2821855B1 (fr) 2001-03-09 2001-03-09 Genes synthetiques et plasmides bacteriens depourvus de cpg

Publications (1)

Publication Number Publication Date
ATE370238T1 true ATE370238T1 (de) 2007-09-15

Family

ID=8860962

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02722336T ATE370238T1 (de) 2001-03-09 2002-03-11 Cpg-freie synthetische gene und bakterielle plasmide

Country Status (9)

Country Link
US (1) US7244609B2 (de)
EP (1) EP1366176B2 (de)
JP (1) JP4264703B2 (de)
AT (1) ATE370238T1 (de)
AU (1) AU2002253226B2 (de)
CA (1) CA2440195C (de)
DE (1) DE60221801T3 (de)
FR (1) FR2821855B1 (de)
WO (1) WO2002072846A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2821855B1 (fr) † 2001-03-09 2004-04-02 Cayla Genes synthetiques et plasmides bacteriens depourvus de cpg
AU2002317771A1 (en) * 2001-06-05 2002-12-16 Cellectis Methods for modifying the cpg content of polynucleotides
EP1572994B1 (de) * 2002-12-20 2007-02-21 Chromagenics B.V. Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
NZ553700A (en) * 2004-11-08 2010-09-30 Chromagenics Bv Selection of host cells expressing protein at high levels using a selectable marker with a non-optimal start codon
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8039230B2 (en) * 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) * 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
JP5291341B2 (ja) * 2004-11-08 2013-09-18 クロマジェニックス ベー ヴェー タンパク質を高レベルで発現する宿主細胞の選定
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
GB0606190D0 (en) 2006-03-28 2006-05-10 Isis Innovation Construct
EP2297326A4 (de) * 2008-06-06 2011-11-16 Aurora Biofuels Inc Vektoren auf vcp-basis zur algenzelltransformation
US20100022393A1 (en) * 2008-07-24 2010-01-28 Bertrand Vick Glyphosate applications in aquaculture
US8314228B2 (en) 2009-02-13 2012-11-20 Aurora Algae, Inc. Bidirectional promoters in Nannochloropsis
US8865468B2 (en) * 2009-10-19 2014-10-21 Aurora Algae, Inc. Homologous recombination in an algal nuclear genome
US8809046B2 (en) 2011-04-28 2014-08-19 Aurora Algae, Inc. Algal elongases
US9029137B2 (en) 2009-06-08 2015-05-12 Aurora Algae, Inc. ACP promoter
US8709765B2 (en) * 2009-07-20 2014-04-29 Aurora Algae, Inc. Manipulation of an alternative respiratory pathway in photo-autotrophs
US20120213848A1 (en) * 2010-11-16 2012-08-23 Hanley Brian P Treatment of Infection Using Single Chain Antibody Gene Therapy
US8722359B2 (en) 2011-01-21 2014-05-13 Aurora Algae, Inc. Genes for enhanced lipid metabolism for accumulation of lipids
US8440805B2 (en) 2011-04-28 2013-05-14 Aurora Algae, Inc. Algal desaturases
US8435777B1 (en) 2012-01-20 2013-05-07 Cayla CPG-free gene for a new secreted reporter protein
US10612034B2 (en) * 2012-06-01 2020-04-07 Exxonmobil Research And Engineering Company Promoters and terminators for use in eukaryotic cells
US9550998B2 (en) 2012-08-29 2017-01-24 Nature Technology Corporation DNA plasmids with improved expression
US20150322439A1 (en) 2012-11-19 2015-11-12 Nature Technology Corporation Replicative minicircle vectors with improved expression
US11124845B2 (en) * 2014-03-18 2021-09-21 The Johns Hopkins University PSMA-based molecular-genetic reporter system
JP6815986B2 (ja) 2014-03-26 2021-01-20 ユニバーシティ オブ メリーランド， カレッジ パーク 大型家畜の接合体における標的化ゲノム編集
US10086089B2 (en) 2015-09-18 2018-10-02 DNARx Systems and methods for nucleic acid expression in vivo
EP3600428A4 (de) 2017-03-23 2020-08-26 Dnarx Systeme und verfahren zur in-vivo-nukleinsäureexpression
GB201714330D0 (en) * 2017-09-06 2017-10-18 Järver Peter Oligonucleotides
EP3456821B2 (de) 2017-09-19 2024-01-24 Deutsches Krebsforschungszentrum Nicht integrierende dna-vektoren zur genetischen modifikation von zellen
WO2019057774A1 (en) 2017-09-19 2019-03-28 Deutsches Krebsforschungszentrum NON-INTEGRATING DNA VECTORS FOR THE GENETIC MODIFICATION OF CELLS
SG11202009009UA (en) 2018-03-21 2020-10-29 Nature Tech Corporation Viral and non-viral nanoplasmid vectors with improved production
CN113943688B (zh) * 2019-07-05 2023-10-20 苏州华赛生物工程技术有限公司 生产胞嘧啶的重组微生物及生产胞嘧啶的方法
CA3151464A1 (en) 2019-09-18 2021-03-25 Bruce C. SCHNEPP Synthetic dna vectors and methods of use
FR3111913A1 (fr) 2020-06-30 2021-12-31 Eyevensys Construction d’adn pour le traitement de pathologies oculaires

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2738842B1 (fr) † 1995-09-15 1997-10-31 Rhone Poulenc Rorer Sa Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique
DK1832657T3 (da) 1998-09-09 2012-12-17 Genzyme Corp Methylering af plasmid-vektorer
US20020065236A1 (en) † 1998-09-09 2002-05-30 Yew Nelson S. CpG reduced plasmids and viral vectors
CA2291367A1 (en) * 1999-12-06 2001-06-06 Isabelle Henry Genetic constructions having a reduced or an increased number of epigenetic control regions and methods of use thereof
FR2821855B1 (fr) † 2001-03-09 2004-04-02 Cayla Genes synthetiques et plasmides bacteriens depourvus de cpg

Also Published As

Publication number Publication date
WO2002072846A9 (fr) 2003-03-20
DE60221801D1 (de) 2007-09-27
US7244609B2 (en) 2007-07-17
FR2821855B1 (fr) 2004-04-02
WO2002072846A3 (fr) 2003-02-27
US20040219677A1 (en) 2004-11-04
EP1366176B2 (de) 2011-10-19
AU2002253226B2 (en) 2007-11-15
EP1366176A2 (de) 2003-12-03
EP1366176B1 (de) 2007-08-15
JP4264703B2 (ja) 2009-05-20
DE60221801T2 (de) 2008-05-08
WO2002072846A2 (fr) 2002-09-19
DE60221801T3 (de) 2012-05-31
FR2821855A1 (fr) 2002-09-13
JP2004524031A (ja) 2004-08-12
CA2440195C (fr) 2011-07-12
CA2440195A1 (fr) 2002-09-19

Similar Documents

Publication Publication Date Title
ATE370238T1 (de) Cpg-freie synthetische gene und bakterielle plasmide
AU2002253226A1 (en) Synthetic genes and bacterial plasmids devoid of CpG
GB0022084D0 (en) Treatment of multiply antibiotic-resistant organisms
EP1606304A4 (de) Genexpressionsregulierende nukleotidsequenzen sowie konstrukte und verfahren unter verwendung davon
DK1320579T3 (da) Metanotrofisk bakteriestamme methylomonas 16A med höj vækstrate
AU2002306849A1 (en) Identification of essential genes in microorganisms
CO5611065A2 (es) Difluorometiltiazolilcarboxanilidas
HK1045326A1 (zh) 微生物的β-葡萄糖甘酸酶基因，基因產品及其用法
GB0202556D0 (en) Novel Protein
HK1154623A1 (en) Isolated luciferases and the use thereof
AU8738401A (en) Novel kallikrein gene
HK1086596A1 (en) Bacterial plasmids
NO20013102D0 (no) Gener, proteiner og deres anvendelse
CA2391368A1 (en) Genes and methods for manipulation of growth
AU2003216273A8 (en) Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
ATE437866T1 (de) Mikrobizide oxathiincarboxamide
DE60231137D1 (de) Reca-negativ und rhab-negativ mikroorganismus
DE50303586D1 (de) Methylthiophencarboxanilide
AP2003002803A0 (en) Global regulators of bacterial pathogenic genes as targets for engineering disease resistance
ATE481479T1 (de) Neue plasmide und deren nutzung
MXPA02004782A (es) Genes del empequenecimiento del sorgo y metodos de uso.
WO2001034810A3 (en) Genes essential for microbial proliferation
AU2003279247A8 (en) The use of bacterial phage associated lysing proteins for treating bacterial dental caries
AU2003260243A8 (en) Dna expression construct for multiple gene expression
DE60013299D1 (de) Phagenresistente mikroorganismen und genetische determinanten für phagenresistenz

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties